Biotechnology in Denmark and Sweden

Biotechnology and Innovation Systems: The Role of Public Policy

Volumn , Issue , 2011, Pages 245-276

  Pålsson, Carl Magnus ^a   Gregersen, Birgitte ^b  

^a LUND UNIVERSITY   (Sweden)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882253993     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4337/9781781001424.00022     Document Type: Chapter

References (49)

1. Asheim, B.T. and M.S. Gertler (2005), 'The geography of innovation: regional innovation systems' in J. Fagerberg, D. Mowery and R. Nelson (eds), The Oxford Handbook of Innovation, New York: Oxford University Press.
2. Bergqvist, H. (2008), A Benchmarking Study of the Swedish and British Life Science Innovation Systems: Comparisons of Policies and Funding, VA 2008:12, Stockholm: VINNOVA.
3. Biotech Sweden (2009), The Swedish Life Science Industry - Guide 2009, Vol. 07, Stockholm: Biotech Sweden.
4. Bitard, P., C. Edquist, L. Hommen and A. Rickne (2008), 'Reconsidering the paradox of high RandD input and low innovation: Sweden', in C. Edquist and L. Homen (eds), Small Country Innovation Systems: Globalization, Change and Policy in Asia and Europe, Cheltenham, UK and Northampton, MA, USA: Edward Elgar.
5. Bloch, C. (2006), 'Biotechnology in Denmark 2995', Working paper 2006/4, The Danish Centre for Studies in Research and Research Policy.
6. Boston Consulting Group, The (2002), Commercial Attractiveness of Biomedical RandD in Medicon Valley: The Role of RandD in Attracting Regional Investments, Copenhagen: The Boston Consulting Group.
7. Christensen, J.L., B. Gregersen, B. Johnson, B.- Å. Lundvall and M. Tomlinson (2008), 'An NSI on transition? Denmark', in C. Edquist and L. Homen (eds.), Small Country Innovation Systems: Globalization, Change and Policy in Asia and Europe, Cheltenham, UK and Northampton, MA, USA: Edward Elgar.
8. Cooke, P. (2005), 'Rational drug design, the knowledge value chain and bioscience megacentres', Cambridge Journal of Economics, 29, 325-41.
9. Critical I (2006), Biotechnology in Europe: Comparative Study for EuropaBio, Brussels: EuropaBio.
10. Danish Agency for Science, Technology and Innovation (Forsknings- og Innovationsstyrelsen) (2010), Erhvervslivets forskning, udvikling og innovation i Danmark, Copenhagen: Danish Agency for Science, Technology and Innovation.
11. D'Este, P. and J. Costa (2007), 'BioPolis: Inventory and analysis of national public policies that stimulate research in biotechnology, its exploitation and commercialisation by industry in Europe in the period 2002-2005; National Report of Sweden', SPRU - Science and Technology Policy Research, Brighton, UK, available at http://ec.europa.eu/research/biosociety/pdf/biopolis_sweden_en.pdf, accessed 2 September 2009.
12. Ejermo, O. and A. Kander (2008), 'The Swedish paradox revisited' in C. Karlsson, B. Johansson and R. Stough (eds), Entrepreneurship and Innovation in Functional Regions, Cheltenham, UK and Northampton, MA, USA: Edward Elgar.
13. Enzing, C. et al. (2007), 'BioPolis: Inventory and analysis of national public policies that stimulate biotechnology research, its exploitation and commercialisation by industry in Europe in the period 2002-2005', Final Report, March 2007, Luxembourg: Offi ce for Offi cial Publications of the European Communities.
14. Ernst & Young (2008), Biotech in Denmark - Growing Stronger, Ernst & Young. Ernst & Young (2010), Beyond Borders - Global Biotechnology Report 2010, Ernst & Young.
15. Ernst & Young (2010), Beyond Borders - Global Biotechnology Report 2010, Ernst & Young
16. European Commission (2003), '2002 European Innovation Scoreboard' Technical Paper No. 7, Biotechnology Innovation Scoreboard, European Commission. Gestrelius, S. (2008), 'Why is Danish life science thriving? A case study of the life science industry in Denmark', VA 2008:09, Stockholm: VINNOVA.
17. Gestrelius, S. (2008), 'Why is Danish life science thriving? A case study of the life science industry in Denmark', VA 2008:09, Stockholm: VINNOVA
18. Gestrelius, S., A. Sandström and T. Dolk (2008), 'Natinal and regional cluster profi les - companies in biotechnology, pharmaceuticals and medical technology in Denmark in comparison with Sweden', VA 2008:10, Stockholm: VINNOVA.
19. Granberg, A. and S. Jacobsson (2006), 'Myths or reality: a scrutiny of dominant beliefs in the Swedish science policy debate', Science and Public Policy, 33(5), 321-40.
20. Graversen, A.B. and J. Rosted (2010), 'Klyngepolitik på et faktabaseret grundlag - Læring fra et pilotstudie af life science i Østersøregionen', FORA Rapport, Copenhagen.
21. IRIS Group (2009), 'Towards a strong biotech cluster in the Copenhagen region: An analysis of the key success actors for internationally leading biotech regions', prepared for: DANISH BIOTECH, The Capital Region of Denmark, and the Danish Association of the Pharmaceutical Industry (Lif), Copenhagen.
22. Lacasa, I.D. (2007), 'BioPolis - Inventory and analysis of national public policies that stimulate research in biotechnology, its exploitation and commercialization by industry in Europe in the period 2002-2005 - National Report of Denmark', Karlsruhe: Fraunhofer Institute for Systems and Innovation Research (Fraunhofer ISI).
23. Lacasa, I.D., T. Reiss and J. Senker (2004), 'Trends and gaps in biotechnology policies in European Member States since 1994', Science and Public Policy, 31(5), 385-95.
24. Lindman, J., J. Timsjö and N. özbek (2008), Looking over the Shoulders of Giants: A Study of the Geography of Big Pharma RandD and Manufacturing Operations, VA 2008:13, Stockholm: VINNOVA.
25. Marklund, G. et al. (2004), The Swedish National Innovation System 1970-2003: A Quantitative International Benchmarking Analysis, VA 2004:01, Stockholm: VINNOVA.
26. McKelvey, M., H. Alm and M. Riccaboni (2003), 'Does co- location matter for formal knowledge collaboration in the Swedish biotechnology- pharmaceutical sector?', Research Policy, 32, 483-501.
27. Medicon Valley Academy (2004), 'From bioscience to new jobs in Medicon Valley: A Medicon Valley Academy strategic report', Copenhagen: Medicon Valley Academy.
28. Ministry of Industry, Employment and Communications (Näringsdepartementet) (2005), 'Läkemedel, bioteknik och medicinteknik: en del av Innovativa Sverige' (Pharmaceuticals, biotechnology and medical technology: a part of Innovative Sweden), December, Stockholm: Ministry of Industry, Employment and Communications.
29. Ministry of Science, Technology and Innovation (2010), 'Research barometer 2010" [in Danish], Forskning: Analyse og Evaluering 7/2010, Copenhagen: Ministry of Science, Technology and Innovation.
30. Moodysson, J., L. Coenen and B. Asheim (2008), 'Explaining spatial patterns of innovation: analytical and synthetic modes of knowledge creation in the Medicon Valley life- science cluster', Environment and Planning A, 40, 1040-56.
31. Norgren, L., R. Nilsson, E. Perez, H. Pohl, A. Sandström and P. Sandgren (2007), Needs- driven RandD Programmes in Sectorial Innovation Systems, VA 2007:15, Stockholm: VINNOVA.
32. OECD (2009), OECD Biotechnology Statistics 2009, Paris: OECD.
33. Patel, P., A. Arundel and M. Hopkins (2008), Sector report: 'Monitoring, analysing trends and identifying challenges in biotechnology', fi nal report, May, Luxembourg: Europe Innova.
34. Reiss, T., S. Hinze and I.D. Lacasa (2004), 'Performance of European Member States in biotechnology' Science and Public Policy, 31(5), 344-58.
35. Reiss, T., R. Lindner and U. Schmoch (2008), 'Developing universities: The evolving role of academic institutions in economic growth. The public and private appropriation of knowledge; Research Report No. 1 on Biotechnology in Europe: Background information on biotechnology industry characteristics and policy environment in Denmark, Germany, Latvia, Russia and Sweden' (unpublished).
36. Reiss, T., I.D. Lacasa, V. Mangematin, F. Corolleur, C. Enzing, C., A. van der Giessen, J. Senker and L. Nesta (2005), Benchmarking of Public Biotechnology Policy. Final report, Contract no. FIF.20030837, Brussels: Commission of the European Communities, Fraunhofer.
37. Rosiello, A. (2005), 'Comparing biotechnology innovation systems: The cases of Scotland, Sweden and Denmark', Innogen Working Paper 35, University of Edinburgh and the Open University.
38. Rosiello, A. (2007), 'The geography of knowledge transfer and innovation in biotechnology: The cases of Scotland, Sweden and Denmark', European Planning Studies, 15(6), July.
39. Royal Swedish Academy of Engineering Sciences (2008), 'Nationell policy för forskning och innovation: En framtidsinriktad omvärldsanalys', IVA- M 381, Stockholm: Royal Swedish Academy of Engineering Sciences.
40. Sandström, A. and L. Norgren (2003), Swedish Biotechnology: Scientifi c Publications, Patenting and Industrial Development, VA 2003:2, Stockholm: VINNOVA.
41. Sandström, A., H. Bergqvist and T. Dolk (2007), National and Regional Cluster Profi les: Companies in Biotechnology, Pharmaceuticals and Medical Technology in Sweden 2007, VA 2007:16, Stockholm: VINNOVA.
42. SwedenBio (2005), Biotechnology in Sweden: A National Biotech Agenda for Growth, SwedenBio, The Swedish Biotechnology Industry Organization.
43. Teigland, R., D. Hallencreutz and P. Lundequist (2005), 'Uppsala BIO: the Life Science Initiative: experiences of and refl ections on starting a regional competitiveness initiative', Research Paper 2005:3, Uppsala: Center for Research on Innovation and Industrial Dynamics (CIND).
44. Vaekstfonden (2007), 'Biotechnology and venture capital in Denmark - perspectives for the future', Copenhagen: Vaekstfonden.
45. Valentin, F., R. Lund Jensen and H. Dahlgren (2008), 'How venture capital shapes emerging bio- clusters: A cross- country comparison', European Planning Studies, 16(3), April.
46. VINNOVA (2002), Eff ective Innovation Systems and Problem- oriented Research for Sustainable Growth: VINNOVA's Strategic Plan 2003-2007, VP 2002:04, Stockholm: VINNOVA.
47. VINNOVA (2005), Strategi för Tillväxt: Bioteknik, en Livsviktig Industri i Sverige, (Strategy for Growth: Biotechnology, a Crucial Industry Sector in Sweden), VP 2005:02, Stockholm: VINNOVA.
48. VINNOVA (2006), End of an era? Governance of Swedish Innovation Policy, (authors: J.G. Thorslund, L. Elg and P. Sandgren), VA 2006:01, Stockholm: VINNOVA.
49. VINNOVA (2009), Internationellt Jämförande Studie av Innovationssystem inom Läkemedel, Bioteknik och Medicinteknik, VA 2009:18, Stockholm: VINNOVA.